Abeona Therapeutics Inc. Stock
Abeona Therapeutics Inc. Stock
Abeona Therapeutics Inc. took a tumble today and lost -€0.160 (-3.760%).
Our community is currently high on Abeona Therapeutics Inc. with 3 Buy predictions and 1 Sell predictions.
Based on the current price of 4.12 € the target price of 34 € shows a potential of 725.24% for Abeona Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Abeona Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. | -3.760% | 5.641% | -40.290% | 45.480% | -12.527% | -86.952% | - |
Ardelyx Inc. | -3.830% | 31.475% | 16.607% | 106.772% | 36.298% | 41.946% | - |
Evolus Inc | 0.830% | 12.150% | -0.826% | 52.866% | 32.597% | 63.265% | - |
Salarius Pharmaceuticals Inc. | -0.980% | -0.971% | -0.971% | -77.826% | -26.486% | -98.326% | -99.993% |
Comments
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $36.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat